This is the protocol for a review and there is no abstract. The objectives are as follows:, To determine the efficacy of alendronate therapy in the prevention and treatment of postmenopausal osteoporosis., The major endpoints will be: (1) reduction of vertebral and non-vertebral fractures, and (2) changes in bone mineral density (3) toxicity of alendronate